Target intelligence / Profile preview

RNA, U6 small nuclear 104, pseudogene (RNU6-104P)

Target
RNU6-104P
Molecular classification
Processed pseudogene, noncoding RNA pseudogene, small nuclear RNA pseudogene
01

Overview

RNU6-104P is a processed pseudogene, meaning it originated from an RNA intermediate of the functional U6 small nuclear RNA gene, usually via retrotransposition events mediated by LINE-1 (L1) elements[4]. Unlike the parent U6 snRNA, which is integral to the spliceosome and involved in intron excision during mRNA maturation[1][4], RNU6-104P does not typically produce functional RNA or protein. While some pseudogenes can have regulatory effects at the RNA level, RNU6-104P is mainly considered nonfunctional "junk DNA," although evolutionary and functional roles for pseudogenes more generally are being investigated[3][5]. The presence of U6 snRNA pseudogene copies in the genome serves as a marker of retrotransposition activity but does not confer receptor or enzyme functionality[4].

Other names
RNU6-104PRNA, U6 small nuclear 104, pseudogeneU6-104 pseudogene
02

Mechanism of action

None relevant. There is no known mechanism of action for drugs targeting RNU6-104P, as it is not an established therapeutic target.

03

Biological functions

None established for the pseudogene itself.Parental U6 snRNA functions in pre-mRNA splicing.The pseudogene is typically nonfunctional.Some pseudogenes have regulatory noncoding RNA roles such as acting as competing endogenous RNAs (ceRNAs), antisense RNAs, or small interfering RNAs.Such roles have not been specifically described for RNU6-104P.
04

Disease associations

None specific to RNU6-104P.Most pseudogenes, including those derived from snRNAs, do not have direct established roles in disease.In some cases, pseudogenes can influence gene regulation in diseases such as cancer.

Beyond the preview

Go deeper on RNA, U6 small nuclear 104, pseudogene (RNU6-104P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 104, pseudogene (RNU6-104P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call